Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Abbott Laboratories
(NY:
ABT
)
102.03
+1.96 (+1.96%)
Official Closing Price
Updated: 7:00 PM EDT, Jul 19, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
11,963,596
Open
100.61
Bid (Size)
102.03 (6)
Ask (Size)
102.50 (1)
Prev. Close
100.07
Today's Range
100.08 - 102.40
52wk Range
89.67 - 121.64
Shares Outstanding
1,750,942,289
Dividend Yield
2.00%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
10 Best Dividend Growth Stocks to Buy and Hold Forever
Today 10:30 EDT
Discover 10 dividend growth powerhouses that could turbocharge your portfolio's long-term performance.
Via
The Motley Fool
Stock Market Rotation Gets Rough; ASML, Eli Lilly, CrowdStrike, UnitedHealth In Focus: Weekly Review
July 19, 2024
The Nasdaq tumbled amid chip woes.
Via
Investor's Business Daily
Performance
YTD
-7.12%
-7.12%
1 Month
-3.49%
-3.49%
3 Month
-4.71%
-4.71%
6 Month
-10.65%
-10.65%
1 Year
-10.98%
-10.98%
More News
Read More
Abbott Labs Makes Marketing Push For New Glucose Monitors, Targets Health-Conscious Consumers
July 19, 2024
Via
Benzinga
Dow Plunges Over 500 Points Following Unexpected Surge In US Jobless Claims
July 19, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Abbott Laboratories Earnings Top Views, Full-Year Guidance Raised
July 18, 2024
Via
Investor's Business Daily
Looking Into Abbott Laboratories's Recent Short Interest
July 10, 2024
Via
Benzinga
7 Safe Stocks to Buy for Volatility Insurance
July 18, 2024
Via
InvestorPlace
Abbott Laboratories (ABT) Q2 2024 Earnings Call Transcript
July 18, 2024
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Why Are Abbott Laboratories Shares Trading Lower?
July 18, 2024
Via
Benzinga
Nasdaq Down Over 100 Points; Abbott Laboratories Earnings Beat Views
July 18, 2024
Via
Benzinga
Topics
Earnings
Exposures
Financial
VIX Stages Double-Digit Spike As Risk Off Takes Over; Chipmakers Fail To Rebound, Weight Loss Giants Eli Lilly, Novo Tumble: What's Driving Markets Thursday?
July 18, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
ABT Stock Earnings: Abbott Laboratories Beats EPS, Beats Revenue for Q2 2024
July 18, 2024
Via
InvestorPlace
Abbott Laboratories Q2 Earnings: Revenue And Profit Beat Estimates, Nudges Up Annual Profit Guidance On Strong Medical Devices Growth
July 18, 2024
Via
Benzinga
Exposures
Product Safety
Why This Leading Health Stock is a Buy No Matter the Market Move
July 18, 2024
Via
MarketBeat
Exposures
COVID-19
Wall Street Gearing Up For Tech-Led Rebound Ahead Of Netflix Earnings: Economist Expects Soft Landing But Says Brace For Bigger Fed Rate Cuts If This Happens
July 18, 2024
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
2 Dividend Stocks to Buy and Hold Forever
July 18, 2024
Via
The Motley Fool
Nasdaq Sees Worst Session Since 2022 As Chip Stocks Tumble After Trump's Taiwan Remarks and Biden's Potential Restrictions
July 18, 2024
Via
Benzinga
Topics
Government
Exposures
Political
D.R. Horton, Netflix And 3 Stocks To Watch Heading Into Thursday
July 18, 2024
Via
Benzinga
Abbott Gears Up For Q2 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
July 18, 2024
Via
Benzinga
Dow Closes At New High As Q2 Earnings Season Heats Up
July 16, 2024
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
Netflix, Goldman Sachs, J&J, ASML Lead Q2 Reports This Week As Analysts See Earnings Growth Accelerating To Fastest In Over 2 Years
July 15, 2024
Via
Benzinga
The 7 Most Undervalued Healthcare Stocks to Buy in July 2024
July 13, 2024
Via
InvestorPlace
U.S. Cannabis Market Soars Amid Legal Reforms, But Safety Concerns Persist
July 11, 2024
From
Financial Buzz Media
Via
GlobeNewswire
7 Healthcare Stocks to Buy for Positive Inflation-Adjusted Returns
July 10, 2024
Via
InvestorPlace
Similac Baby Formula Maker Abbott And Reckitt Face Hundreds Of Baby Formula Lawsuits
July 08, 2024
Via
Benzinga
Topics
Lawsuit
Exposures
Financial
Legal
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.